

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 6.13094191 |
| 2 | modulation by symbiont of host immune response (GO:0052553) | 6.13094191 |
| 3 | positive regulation by symbiont of host defense response (GO:0052509) | 6.13094191 |
| 4 | modulation by symbiont of host defense response (GO:0052031) | 6.13094191 |
| 5 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 6.13094191 |
| 6 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 6.13094191 |
| 7 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.93228753 |
| 8 | detection of other organism (GO:0098543) | 4.79429323 |
| 9 | macrophage activation involved in immune response (GO:0002281) | 4.74914192 |
| 10 | detection of bacterium (GO:0016045) | 4.69488916 |
| 11 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.66457036 |
| 12 | neutrophil activation involved in immune response (GO:0002283) | 4.50764728 |
| 13 | response to peptidoglycan (GO:0032494) | 4.36475186 |
| 14 | positive regulation of interferon-alpha production (GO:0032727) | 4.27608277 |
| 15 | microglial cell activation (GO:0001774) | 4.21016557 |
| 16 | immunoglobulin mediated immune response (GO:0016064) | 4.17843717 |
| 17 | response to host immune response (GO:0052572) | 4.17019059 |
| 18 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 4.17019059 |
| 19 | negative regulation of cell killing (GO:0031342) | 4.15299496 |
| 20 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 4.15299496 |
| 21 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.11572730 |
| 22 | regulation of interferon-alpha production (GO:0032647) | 4.07156439 |
| 23 | respiratory burst (GO:0045730) | 4.00143179 |
| 24 | detection of external biotic stimulus (GO:0098581) | 3.99266558 |
| 25 | response to host (GO:0075136) | 3.85615680 |
| 26 | response to host defenses (GO:0052200) | 3.85615680 |
| 27 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.85615680 |
| 28 | regulation of gamma-delta T cell activation (GO:0046643) | 3.76758383 |
| 29 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.76139120 |
| 30 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.72595185 |
| 31 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 3.71506936 |
| 32 | positive regulation of antigen processing and presentation (GO:0002579) | 3.69345477 |
| 33 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 3.69001029 |
| 34 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 3.69001029 |
| 35 | negative regulation of erythrocyte differentiation (GO:0045647) | 3.66288429 |
| 36 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.63086213 |
| 37 | detection of molecule of bacterial origin (GO:0032490) | 3.59871392 |
| 38 | myeloid cell activation involved in immune response (GO:0002275) | 3.52344592 |
| 39 | antigen processing and presentation of endogenous antigen (GO:0019883) | 3.51819583 |
| 40 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.50161376 |
| 41 | detection of biotic stimulus (GO:0009595) | 3.48908086 |
| 42 | cellular extravasation (GO:0045123) | 3.45244358 |
| 43 | granulocyte activation (GO:0036230) | 3.44173174 |
| 44 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.42561786 |
| 45 | macrophage activation (GO:0042116) | 3.40609849 |
| 46 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.38620315 |
| 47 | germinal center formation (GO:0002467) | 3.34466610 |
| 48 | neutrophil activation (GO:0042119) | 3.32610852 |
| 49 | leukocyte migration involved in inflammatory response (GO:0002523) | 3.31397790 |
| 50 | response to interleukin-15 (GO:0070672) | 3.30040456 |
| 51 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.29031809 |
| 52 | regulation of T cell tolerance induction (GO:0002664) | 3.28460908 |
| 53 | response to muramyl dipeptide (GO:0032495) | 3.22750833 |
| 54 | interferon-gamma-mediated signaling pathway (GO:0060333) | 3.22736328 |
| 55 | positive regulation of mast cell activation (GO:0033005) | 3.22733459 |
| 56 | regulation of gamma-delta T cell differentiation (GO:0045586) | 3.22022679 |
| 57 | regulation of tolerance induction (GO:0002643) | 3.15522747 |
| 58 | leukocyte aggregation (GO:0070486) | 3.13116768 |
| 59 | negative regulation of T cell mediated immunity (GO:0002710) | 3.12080922 |
| 60 | NIK/NF-kappaB signaling (GO:0038061) | 3.10234068 |
| 61 | regulation of T-helper 2 cell differentiation (GO:0045628) | 3.09559576 |
| 62 | defense response to protozoan (GO:0042832) | 3.06634540 |
| 63 | regulation of antigen processing and presentation (GO:0002577) | 3.04951878 |
| 64 | B cell mediated immunity (GO:0019724) | 3.03134376 |
| 65 | negative regulation of phagocytosis (GO:0050765) | 3.02676295 |
| 66 | lymphocyte chemotaxis (GO:0048247) | 3.01963322 |
| 67 | cellular response to interleukin-15 (GO:0071350) | 3.00384944 |
| 68 | actin nucleation (GO:0045010) | 2.99403796 |
| 69 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.99222664 |
| 70 | regulation of mononuclear cell migration (GO:0071675) | 2.96877721 |
| 71 | positive thymic T cell selection (GO:0045059) | 2.96454083 |
| 72 | B cell receptor signaling pathway (GO:0050853) | 2.96161118 |
| 73 | myeloid dendritic cell differentiation (GO:0043011) | 2.94744618 |
| 74 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 2.94069924 |
| 75 | negative regulation of interleukin-12 production (GO:0032695) | 2.93014590 |
| 76 | negative regulation of cytokine production involved in immune response (GO:0002719) | 2.92606177 |
| 77 | regulation of cholesterol storage (GO:0010885) | 2.92438333 |
| 78 | positive regulation of B cell differentiation (GO:0045579) | 2.91021070 |
| 79 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.89578039 |
| 80 | positive regulation of interferon-beta production (GO:0032728) | 2.89551171 |
| 81 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.89256096 |
| 82 | regulation of natural killer cell mediated immunity (GO:0002715) | 2.89162370 |
| 83 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 2.89162370 |
| 84 | regulation of mast cell degranulation (GO:0043304) | 2.86705062 |
| 85 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 2.85204383 |
| 86 | production of molecular mediator involved in inflammatory response (GO:0002532) | 2.85127449 |
| 87 | leukocyte degranulation (GO:0043299) | 2.84507101 |
| 88 | negative regulation of innate immune response (GO:0045824) | 2.84482624 |
| 89 | cellular response to type I interferon (GO:0071357) | 2.84135084 |
| 90 | type I interferon signaling pathway (GO:0060337) | 2.84135084 |
| 91 | response to protozoan (GO:0001562) | 2.83717455 |
| 92 | neutrophil chemotaxis (GO:0030593) | 2.83343353 |
| 93 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.83263365 |
| 94 | regulation of B cell differentiation (GO:0045577) | 2.83165230 |
| 95 | pinocytosis (GO:0006907) | 2.83049609 |
| 96 | response to type I interferon (GO:0034340) | 2.81982807 |
| 97 | myeloid dendritic cell activation (GO:0001773) | 2.81340316 |
| 98 | regulation of tumor necrosis factor biosynthetic process (GO:0042534) | 2.80790905 |
| 99 | regulation of leukocyte degranulation (GO:0043300) | 2.80567624 |
| 100 | negative regulation of interleukin-6 production (GO:0032715) | 2.80343764 |
| 101 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.80117085 |
| 102 | positive regulation of mast cell degranulation (GO:0043306) | 2.80117085 |
| 103 | negative regulation of type 2 immune response (GO:0002829) | 2.75977103 |
| 104 | phagosome maturation (GO:0090382) | 2.75935289 |
| 105 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 2.75615001 |
| 106 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 2.75601397 |
| 107 | positive regulation of Cdc42 GTPase activity (GO:0043089) | 2.74828136 |
| 108 | neutrophil migration (GO:1990266) | 2.73986053 |
| 109 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.72919573 |
| 110 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.72684842 |
| 111 | myeloid leukocyte activation (GO:0002274) | 2.71984466 |
| 112 | neutrophil mediated immunity (GO:0002446) | 2.68632602 |
| 113 | regulation of mast cell activation (GO:0033003) | 2.66775112 |
| 114 | regulation of myeloid leukocyte mediated immunity (GO:0002886) | 2.66141168 |
| 115 | I-kappaB phosphorylation (GO:0007252) | 2.65215594 |
| 116 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.64997209 |
| 117 | positive regulation of lamellipodium assembly (GO:0010592) | 2.63572271 |
| 118 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 2.63339457 |
| 119 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.62440639 |
| 120 | natural killer cell mediated immunity (GO:0002228) | 2.62440639 |
| 121 | regulation of mast cell activation involved in immune response (GO:0033006) | 2.62270249 |
| 122 | reactive oxygen species biosynthetic process (GO:1903409) | 2.61608663 |
| 123 | leukocyte cell-cell adhesion (GO:0007159) | 2.61051613 |
| 124 | positive regulation of interferon-gamma biosynthetic process (GO:0045078) | 2.61035427 |
| 125 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.60171541 |
| 126 | negative regulation of interleukin-17 production (GO:0032700) | 2.58016597 |
| 127 | JAK-STAT cascade involved in growth hormone signaling pathway (GO:0060397) | 2.57935167 |
| 128 | low-density lipoprotein particle clearance (GO:0034383) | 2.57290212 |
| 129 | dendritic cell differentiation (GO:0097028) | 2.57263967 |
| 130 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.56019923 |
| 131 | actin filament polymerization (GO:0030041) | 2.55558042 |
| 132 | leukocyte mediated cytotoxicity (GO:0001909) | 2.54841644 |
| 133 | positive regulation of leukocyte degranulation (GO:0043302) | 2.54337414 |
| 134 | regulation of dendritic cell antigen processing and presentation (GO:0002604) | 2.54103848 |
| 135 | positive regulation of macrophage cytokine production (GO:0060907) | 2.53973627 |
| 136 | regulation of regulated secretory pathway (GO:1903305) | 2.53057506 |
| 137 | T cell migration (GO:0072678) | 2.52595519 |
| 138 | mature B cell differentiation (GO:0002335) | 2.50624783 |
| 139 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 2.50019254 |
| 140 | apoptotic cell clearance (GO:0043277) | 2.49158726 |
| 141 | cellular response to interferon-gamma (GO:0071346) | 2.48990056 |
| 142 | granulocyte chemotaxis (GO:0071621) | 2.48367172 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 5.74881564 |
| 2 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 4.79927572 |
| 3 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.23163586 |
| 4 | * IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.05264887 |
| 5 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.83827382 |
| 6 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.39676519 |
| 7 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 3.28198669 |
| 8 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 3.10873742 |
| 9 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 3.05104541 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.02912594 |
| 11 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.02145673 |
| 12 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.93109213 |
| 13 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.89431820 |
| 14 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.71622857 |
| 15 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.43956035 |
| 16 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.43113324 |
| 17 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.42139574 |
| 18 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.36948793 |
| 19 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.34024176 |
| 20 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 2.28414488 |
| 21 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 2.15631051 |
| 22 | * SPI1_23127762_ChIP-Seq_K562_Human | 2.10034100 |
| 23 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.06757857 |
| 24 | VDR_24763502_ChIP-Seq_THP-1_Human | 2.06643236 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 2.04197973 |
| 26 | MAF_26560356_Chip-Seq_TH1_Human | 1.92067815 |
| 27 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.91968309 |
| 28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.91500370 |
| 29 | * KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.87174992 |
| 30 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.87120910 |
| 31 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 1.83756450 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.79969003 |
| 33 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.78202159 |
| 34 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 1.77379161 |
| 35 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.76864082 |
| 36 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.74431020 |
| 37 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.66334609 |
| 38 | MYB_26560356_Chip-Seq_TH2_Human | 1.62560619 |
| 39 | * KDM2B_26808549_Chip-Seq_DND41_Human | 1.61908448 |
| 40 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.59911576 |
| 41 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.58348825 |
| 42 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.58193542 |
| 43 | * LXR_22292898_ChIP-Seq_THP-1_Human | 1.57152796 |
| 44 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.56913815 |
| 45 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.53161998 |
| 46 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.50801999 |
| 47 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.50543040 |
| 48 | * KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.44293947 |
| 49 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42790779 |
| 50 | * UTX_26944678_Chip-Seq_JUKART_Human | 1.40651141 |
| 51 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.40188368 |
| 52 | MYC_22102868_ChIP-Seq_BL_Human | 1.39420378 |
| 53 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.36916028 |
| 54 | MYB_26560356_Chip-Seq_TH1_Human | 1.35502559 |
| 55 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.33995490 |
| 56 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.30306263 |
| 57 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 1.29789257 |
| 58 | * KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.29138718 |
| 59 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.28675487 |
| 60 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 1.28376554 |
| 61 | BCOR_27268052_Chip-Seq_Bcells_Human | 1.27009600 |
| 62 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.24854654 |
| 63 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.23474168 |
| 64 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.21624171 |
| 65 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.19989126 |
| 66 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19817959 |
| 67 | * SA1_27219007_Chip-Seq_ERYTHROID_Human | 1.17693230 |
| 68 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.16608560 |
| 69 | * GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.16209959 |
| 70 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.15810553 |
| 71 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 1.14857458 |
| 72 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14304894 |
| 73 | MAF_26560356_Chip-Seq_TH2_Human | 1.12802398 |
| 74 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.08676443 |
| 75 | P68_20966046_ChIP-Seq_HELA_Human | 1.08031050 |
| 76 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.07828432 |
| 77 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.07344312 |
| 78 | RACK7_27058665_Chip-Seq_MCF-7_Human | 1.06647444 |
| 79 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.06493317 |
| 80 | * NCOR1_26117541_ChIP-Seq_K562_Human | 1.06295236 |
| 81 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.04978882 |
| 82 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.04805759 |
| 83 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.04797749 |
| 84 | * GATA3_27048872_Chip-Seq_THYMUS_Human | 1.04337528 |
| 85 | ELF1_20517297_ChIP-Seq_JURKAT_Human | 1.03433474 |
| 86 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.01817406 |
| 87 | GATA1_19941826_ChIP-Seq_K562_Human | 1.00299802 |
| 88 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.99452402 |
| 89 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.99191983 |
| 90 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 0.98651893 |
| 91 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 0.98329867 |
| 92 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.97279203 |
| 93 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.96341224 |
| 94 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.96238290 |
| 95 | * KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.94818757 |
| 96 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.94200596 |
| 97 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.94196049 |
| 98 | * GATA2_22383799_ChIP-Seq_G1ME_Mouse | 0.94047073 |
| 99 | * KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.93663827 |
| 100 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 0.91757103 |
| 101 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.91687628 |
| 102 | * SMC4_20622854_ChIP-Seq_HELA_Human | 0.91366856 |
| 103 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 0.90093250 |
| 104 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 0.88993258 |
| 105 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.88739560 |
| 106 | * P300_27058665_Chip-Seq_ZR-75-30cells_Human | 0.83662430 |
| 107 | * GATA3_26560356_Chip-Seq_TH2_Human | 0.83615761 |
| 108 | * GATA1_22383799_ChIP-Seq_G1ME_Mouse | 0.83459389 |
| 109 | * KLF4_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.83369235 |
| 110 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.81669850 |
| 111 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.81259232 |
| 112 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.80687913 |
| 113 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 0.80561360 |
| 114 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.79573819 |
| 115 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 0.78945197 |
| 116 | * SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 0.77244182 |
| 117 | ELF3_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.77147886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003303_peritoneal_inflammation | 4.85401223 |
| 2 | MP0005058_abnormal_lysosome_morphology | 3.57884665 |
| 3 | MP0001835_abnormal_antigen_presentation | 3.57823810 |
| 4 | MP0003436_decreased_susceptibility_to | 3.43821150 |
| 5 | MP0006082_CNS_inflammation | 3.35273687 |
| 6 | MP0004510_myositis | 3.19001857 |
| 7 | MP0002419_abnormal_innate_immunity | 2.91612942 |
| 8 | MP0009785_altered_susceptibility_to | 2.90168625 |
| 9 | MP0003172_abnormal_lysosome_physiology | 2.71823266 |
| 10 | MP0005000_abnormal_immune_tolerance | 2.68145012 |
| 11 | MP0002148_abnormal_hypersensitivity_rea | 2.63759072 |
| 12 | MP0005025_abnormal_response_to | 2.56621602 |
| 13 | MP0001790_abnormal_immune_system | 2.48822218 |
| 14 | MP0005387_immune_system_phenotype | 2.48822218 |
| 15 | MP0003300_gastrointestinal_ulcer | 2.47351320 |
| 16 | MP0002452_abnormal_antigen_presenting | 2.38762213 |
| 17 | MP0009840_abnormal_foam_cell | 2.38112326 |
| 18 | MP0000685_abnormal_immune_system | 2.33427314 |
| 19 | MP0005671_abnormal_response_to | 2.30854062 |
| 20 | MP0001800_abnormal_humoral_immune | 2.20707942 |
| 21 | MP0005464_abnormal_platelet_physiology | 2.18640853 |
| 22 | MP0002723_abnormal_immune_serum | 2.17725196 |
| 23 | MP0003075_altered_response_to | 2.14675504 |
| 24 | MP0001819_abnormal_immune_cell | 2.07812046 |
| 25 | MP0003724_increased_susceptibility_to | 2.06622166 |
| 26 | MP0002420_abnormal_adaptive_immunity | 2.05184999 |
| 27 | MP0003191_abnormal_cellular_cholesterol | 2.04474809 |
| 28 | MP0003763_abnormal_thymus_physiology | 1.99978751 |
| 29 | MP0001533_abnormal_skeleton_physiology | 1.98607806 |
| 30 | MP0000604_amyloidosis | 1.96913347 |
| 31 | MP0008260_abnormal_autophagy | 1.94925862 |
| 32 | MP0005451_abnormal_body_composition | 1.90772536 |
| 33 | MP0004947_skin_inflammation | 1.83435004 |
| 34 | MP0003448_altered_tumor_morphology | 1.80417408 |
| 35 | MP0003183_abnormal_peptide_metabolism | 1.77079922 |
| 36 | MP0005167_abnormal_blood-brain_barrier | 1.75401628 |
| 37 | MP0000343_altered_response_to | 1.73044035 |
| 38 | MP0001845_abnormal_inflammatory_respons | 1.72314967 |
| 39 | MP0005310_abnormal_salivary_gland | 1.72266773 |
| 40 | MP0002405_respiratory_system_inflammati | 1.70386682 |
| 41 | MP0005166_decreased_susceptibility_to | 1.66506630 |
| 42 | MP0009278_abnormal_bone_marrow | 1.66264454 |
| 43 | MP0003690_abnormal_glial_cell | 1.59288672 |
| 44 | MP0010155_abnormal_intestine_physiology | 1.55832121 |
| 45 | MP0008469_abnormal_protein_level | 1.51780984 |
| 46 | MP0000569_abnormal_digit_pigmentation | 1.47908196 |
| 47 | MP0000716_abnormal_immune_system | 1.45494201 |
| 48 | MP0001853_heart_inflammation | 1.44208879 |
| 49 | MP0002132_abnormal_respiratory_system | 1.42420926 |
| 50 | MP0002998_abnormal_bone_remodeling | 1.38512610 |
| 51 | MP0004858_abnormal_nervous_system | 1.36581536 |
| 52 | MP0002398_abnormal_bone_marrow | 1.36166300 |
| 53 | MP0004859_abnormal_synaptic_plasticity | 1.35676220 |
| 54 | MP0002396_abnormal_hematopoietic_system | 1.32196817 |
| 55 | MP0009764_decreased_sensitivity_to | 1.30352645 |
| 56 | MP0005397_hematopoietic_system_phenotyp | 1.30149691 |
| 57 | MP0001545_abnormal_hematopoietic_system | 1.30149691 |
| 58 | MP0005076_abnormal_cell_differentiation | 1.28469584 |
| 59 | MP0000858_altered_metastatic_potential | 1.28007789 |
| 60 | MP0009333_abnormal_splenocyte_physiolog | 1.25667230 |
| 61 | MP0001851_eye_inflammation | 1.22141742 |
| 62 | MP0000689_abnormal_spleen_morphology | 1.20143029 |
| 63 | MP0000703_abnormal_thymus_morphology | 1.19138246 |
| 64 | MP0002138_abnormal_hepatobiliary_system | 1.18963153 |
| 65 | MP0003566_abnormal_cell_adhesion | 1.16577993 |
| 66 | MP0002166_altered_tumor_susceptibility | 1.16488255 |
| 67 | MP0002429_abnormal_blood_cell | 1.16091809 |
| 68 | MP0002006_tumorigenesis | 1.13461740 |
| 69 | MP0003806_abnormal_nucleotide_metabolis | 1.12036642 |
| 70 | MP0003866_abnormal_defecation | 1.10392611 |
| 71 | MP0002722_abnormal_immune_system | 1.09699610 |
| 72 | MP0001873_stomach_inflammation | 1.09621188 |
| 73 | MP0010307_abnormal_tumor_latency | 1.02226219 |
| 74 | MP0003828_pulmonary_edema | 1.02095344 |
| 75 | MP0002277_abnormal_respiratory_mucosa | 1.01603984 |
| 76 | MP0005174_abnormal_tail_pigmentation | 1.01568885 |
| 77 | MP0001663_abnormal_digestive_system | 1.01367154 |
| 78 | MP0002933_joint_inflammation | 1.00801434 |
| 79 | MP0003705_abnormal_hypodermis_morpholog | 0.95948040 |
| 80 | MP0002254_reproductive_system_inflammat | 0.94954933 |
| 81 | MP0000465_gastrointestinal_hemorrhage | 0.90705418 |
| 82 | MP0005164_abnormal_response_to | 0.89903305 |
| 83 | MP0000249_abnormal_blood_vessel | 0.87923872 |
| 84 | MP0003091_abnormal_cell_migration | 0.85763951 |
| 85 | MP0003045_fibrosis | 0.84962037 |
| 86 | MP0004381_abnormal_hair_follicle | 0.84259863 |
| 87 | MP0003453_abnormal_keratinocyte_physiol | 0.83520300 |
| 88 | MP0010234_abnormal_vibrissa_follicle | 0.81542698 |
| 89 | MP0003329_amyloid_beta_deposits | 0.76109473 |
| 90 | MP0005083_abnormal_biliary_tract | 0.75848475 |
| 91 | MP0003656_abnormal_erythrocyte_physiolo | 0.75385481 |
| 92 | MP0004130_abnormal_muscle_cell | 0.74823529 |
| 93 | MP0001501_abnormal_sleep_pattern | 0.74724531 |
| 94 | MP0000490_abnormal_crypts_of | 0.74380914 |
| 95 | MP0005390_skeleton_phenotype | 0.73445206 |
| 96 | MP0002090_abnormal_vision | 0.72963310 |
| 97 | MP0008004_abnormal_stomach_pH | 0.72549949 |
| 98 | MP0009763_increased_sensitivity_to | 0.72181380 |
| 99 | MP0004883_abnormal_blood_vessel | 0.69842531 |
| 100 | MP0001849_ear_inflammation | 0.69726717 |
| 101 | MP0003633_abnormal_nervous_system | 0.69613872 |
| 102 | MP0002877_abnormal_melanocyte_morpholog | 0.66585999 |
| 103 | MP0002064_seizures | 0.66199424 |
| 104 | MP0003879_abnormal_hair_cell | 0.65006859 |
| 105 | MP0008874_decreased_physiological_sensi | 0.63892851 |
| 106 | MP0000920_abnormal_myelination | 0.63420912 |
| 107 | MP0004808_abnormal_hematopoietic_stem | 0.63189967 |
| 108 | MP0010352_gastrointestinal_tract_polyps | 0.61413965 |
| 109 | MP0009765_abnormal_xenobiotic_induced | 0.59868118 |
| 110 | MP0008873_increased_physiological_sensi | 0.59724243 |
| 111 | MP0003795_abnormal_bone_structure | 0.59040995 |
| 112 | MP0005319_abnormal_enzyme/_coenzyme | 0.56340345 |
| 113 | MP0005381_digestive/alimentary_phenotyp | 0.56305186 |
| 114 | MP0005023_abnormal_wound_healing | 0.55871226 |
| 115 | MP0004185_abnormal_adipocyte_glucose | 0.54345538 |
| 116 | MP0002332_abnormal_exercise_endurance | 0.50221745 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Recurrent abscess formation (HP:0002722) | 6.16001187 |
| 2 | Eczematoid dermatitis (HP:0000976) | 6.01904766 |
| 3 | Increased cerebral lipofuscin (HP:0011813) | 5.42012400 |
| 4 | Recurrent bacterial skin infections (HP:0005406) | 5.35803628 |
| 5 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.95211986 |
| 6 | Systemic lupus erythematosus (HP:0002725) | 4.83206408 |
| 7 | Abnormality of macrophages (HP:0004311) | 4.60919802 |
| 8 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 4.53314761 |
| 9 | Vacuolated lymphocytes (HP:0001922) | 4.26658740 |
| 10 | Dysostosis multiplex (HP:0000943) | 4.01035741 |
| 11 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 3.95279086 |
| 12 | Abnormality of glycolipid metabolism (HP:0010969) | 3.95279086 |
| 13 | Abnormality of liposaccharide metabolism (HP:0010968) | 3.95279086 |
| 14 | Mediastinal lymphadenopathy (HP:0100721) | 3.87431478 |
| 15 | Myositis (HP:0100614) | 3.85140567 |
| 16 | Obstructive lung disease (HP:0006536) | 3.78335573 |
| 17 | Chronic obstructive pulmonary disease (HP:0006510) | 3.78335573 |
| 18 | Elevated erythrocyte sedimentation rate (HP:0003565) | 3.71387330 |
| 19 | Axonal loss (HP:0003447) | 3.50913105 |
| 20 | Stomatitis (HP:0010280) | 3.50229702 |
| 21 | Disinhibition (HP:0000734) | 3.49516187 |
| 22 | Glomerulonephritis (HP:0000099) | 3.47360095 |
| 23 | Orchitis (HP:0100796) | 3.37207172 |
| 24 | Mucopolysacchariduria (HP:0008155) | 3.34784680 |
| 25 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.34784680 |
| 26 | Gingivitis (HP:0000230) | 3.30445983 |
| 27 | Recurrent skin infections (HP:0001581) | 3.26636738 |
| 28 | Autoimmune thrombocytopenia (HP:0001973) | 3.22296079 |
| 29 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.20483737 |
| 30 | Recurrent fungal infections (HP:0002841) | 3.19220260 |
| 31 | Encephalitis (HP:0002383) | 3.16331718 |
| 32 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 3.14986913 |
| 33 | Loss of speech (HP:0002371) | 3.08032371 |
| 34 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 3.07556152 |
| 35 | Abnormality of polysaccharide metabolism (HP:0011012) | 3.07556152 |
| 36 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 3.07556152 |
| 37 | Myocardial infarction (HP:0001658) | 2.93586667 |
| 38 | Optic neuritis (HP:0100653) | 2.92837229 |
| 39 | Retrobulbar optic neuritis (HP:0100654) | 2.92837229 |
| 40 | Interstitial pulmonary disease (HP:0006530) | 2.86549353 |
| 41 | Prolonged bleeding time (HP:0003010) | 2.72760903 |
| 42 | Chronic otitis media (HP:0000389) | 2.71865040 |
| 43 | Keratoconjunctivitis (HP:0001096) | 2.70138680 |
| 44 | Pustule (HP:0200039) | 2.69946745 |
| 45 | Urticaria (HP:0001025) | 2.69886409 |
| 46 | Cellulitis (HP:0100658) | 2.68092215 |
| 47 | Hematochezia (HP:0002573) | 2.66976917 |
| 48 | Mutism (HP:0002300) | 2.63702834 |
| 49 | Basal ganglia calcification (HP:0002135) | 2.60078659 |
| 50 | Recurrent viral infections (HP:0004429) | 2.55414223 |
| 51 | Episodic fever (HP:0001954) | 2.55008189 |
| 52 | Vasculitis (HP:0002633) | 2.52007006 |
| 53 | Spontaneous hematomas (HP:0007420) | 2.48517918 |
| 54 | Diminished motivation (HP:0000745) | 2.45448247 |
| 55 | T lymphocytopenia (HP:0005403) | 2.43176140 |
| 56 | Nasal polyposis (HP:0100582) | 2.42330623 |
| 57 | Purpura (HP:0000979) | 2.41908588 |
| 58 | Epistaxis (HP:0000421) | 2.41860908 |
| 59 | Malnutrition (HP:0004395) | 2.41777948 |
| 60 | Increased serum ferritin (HP:0003281) | 2.39887324 |
| 61 | Hypochromic anemia (HP:0001931) | 2.39376231 |
| 62 | Nephritis (HP:0000123) | 2.39111594 |
| 63 | Periodontitis (HP:0000704) | 2.38900772 |
| 64 | Abnormality of the nasal mucosa (HP:0000433) | 2.38115570 |
| 65 | Meningitis (HP:0001287) | 2.37114993 |
| 66 | Apathy (HP:0000741) | 2.35876450 |
| 67 | Arterial thrombosis (HP:0004420) | 2.35126841 |
| 68 | Neuronal loss in central nervous system (HP:0002529) | 2.33187340 |
| 69 | Abnormality of T cell number (HP:0011839) | 2.29987879 |
| 70 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.28283081 |
| 71 | Inflammation of the large intestine (HP:0002037) | 2.27019036 |
| 72 | Anorexia (HP:0002039) | 2.26420453 |
| 73 | Agnosia (HP:0010524) | 2.25149406 |
| 74 | Amyloidosis (HP:0011034) | 2.24698702 |
| 75 | Pulmonary embolism (HP:0002204) | 2.24307890 |
| 76 | Abnormality of complement system (HP:0005339) | 2.23589372 |
| 77 | J-shaped sella turcica (HP:0002680) | 2.23241549 |
| 78 | Hypochromic microcytic anemia (HP:0004840) | 2.21585821 |
| 79 | Granulocytopenia (HP:0001913) | 2.21268617 |
| 80 | Colitis (HP:0002583) | 2.20725022 |
| 81 | Complement deficiency (HP:0004431) | 2.19237423 |
| 82 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.19229941 |
| 83 | Recurrent cutaneous fungal infections (HP:0011370) | 2.19229941 |
| 84 | Peritonitis (HP:0002586) | 2.18453293 |
| 85 | Tetraparesis (HP:0002273) | 2.17469564 |
| 86 | Premature loss of primary teeth (HP:0006323) | 2.16692758 |
| 87 | Panhypogammaglobulinemia (HP:0003139) | 2.16118952 |
| 88 | Sepsis (HP:0100806) | 2.16030749 |
| 89 | Gastrointestinal inflammation (HP:0004386) | 2.15396731 |
| 90 | Pulmonary infiltrates (HP:0002113) | 2.14594217 |
| 91 | Inappropriate behavior (HP:0000719) | 2.13409695 |
| 92 | Abnormality of T cells (HP:0002843) | 2.10688540 |
| 93 | Lymphopenia (HP:0001888) | 2.09156067 |
| 94 | Supranuclear gaze palsy (HP:0000605) | 2.06964754 |
| 95 | Abnormality of iron homeostasis (HP:0011031) | 2.06950181 |
| 96 | Gastrointestinal stroma tumor (HP:0100723) | 2.06680682 |
| 97 | Increased IgE level (HP:0003212) | 2.05055204 |
| 98 | Hepatosplenomegaly (HP:0001433) | 2.04092358 |
| 99 | Slow saccadic eye movements (HP:0000514) | 2.03471842 |
| 100 | Thoracic kyphosis (HP:0002942) | 2.03318035 |
| 101 | Skin ulcer (HP:0200042) | 2.02117699 |
| 102 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 2.00847241 |
| 103 | Segmental peripheral demyelination/remyelination (HP:0003481) | 2.00689066 |
| 104 | Glomerulopathy (HP:0100820) | 1.99265524 |
| 105 | Thick nail (HP:0001805) | 1.98187421 |
| 106 | Petechiae (HP:0000967) | 1.97957057 |
| 107 | Abnormality of the lumbar spine (HP:0100712) | 1.97938947 |
| 108 | Abnormality of the pleura (HP:0002103) | 1.95205676 |
| 109 | Polygenic inheritance (HP:0010982) | 1.94548320 |
| 110 | Parkinsonism with favorable response to dopaminergic medication (HP:0002548) | 1.93875943 |
| 111 | Leukocytosis (HP:0001974) | 1.92876617 |
| 112 | Papilledema (HP:0001085) | 1.91887853 |
| 113 | Gangrene (HP:0100758) | 1.91581528 |
| 114 | Agammaglobulinemia (HP:0004432) | 1.91491906 |
| 115 | Impaired platelet aggregation (HP:0003540) | 1.90801706 |
| 116 | Abnormal platelet function (HP:0011869) | 1.90801706 |
| 117 | Hypergammaglobulinemia (HP:0010702) | 1.90756481 |
| 118 | Osteomyelitis (HP:0002754) | 1.90656518 |
| 119 | Frequent falls (HP:0002359) | 1.90423702 |
| 120 | Chest pain (HP:0100749) | 1.88842833 |
| 121 | Global brain atrophy (HP:0002283) | 1.88561992 |
| 122 | Acne (HP:0001061) | 1.88321055 |
| 123 | Restrictive lung disease (HP:0002091) | 1.87897260 |
| 124 | Increased IgM level (HP:0003496) | 1.87175572 |
| 125 | Gingival bleeding (HP:0000225) | 1.86799626 |
| 126 | Hemoptysis (HP:0002105) | 1.86052000 |
| 127 | Abnormality of the peritoneum (HP:0002585) | 1.84972385 |
| 128 | Abnormality of T cell physiology (HP:0011840) | 1.84186393 |
| 129 | Bone pain (HP:0002653) | 1.83964640 |
| 130 | Asymmetric septal hypertrophy (HP:0001670) | 1.81164898 |
| 131 | Increased CSF protein (HP:0002922) | 1.81094457 |
| 132 | Upper motor neuron abnormality (HP:0002127) | 1.81060311 |
| 133 | Abnormality of binocular vision (HP:0011514) | 1.78443307 |
| 134 | Diplopia (HP:0000651) | 1.78443307 |
| 135 | Keratoconjunctivitis sicca (HP:0001097) | 1.76876370 |
| 136 | Gastrointestinal infarctions (HP:0005244) | 1.76209245 |
| 137 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.76202829 |
| 138 | Esophageal varix (HP:0002040) | 1.73724632 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | RIPK4 | 4.17030388 |
| 2 | BLK | 3.29707491 |
| 3 | TBK1 | 3.20740841 |
| 4 | PRPF4B | 3.03286475 |
| 5 | TRIB3 | 2.87199264 |
| 6 | TYK2 | 2.46853247 |
| 7 | MAP4K1 | 2.39516116 |
| 8 | MAP3K14 | 2.22523620 |
| 9 | ERN1 | 2.10318635 |
| 10 | FES | 2.08836388 |
| 11 | IRAK4 | 2.03453256 |
| 12 | KIT | 1.98392624 |
| 13 | MAP3K9 | 1.94002032 |
| 14 | PKN2 | 1.91715161 |
| 15 | MAP3K13 | 1.89299521 |
| 16 | IRAK3 | 1.83840918 |
| 17 | TGFBR2 | 1.83077960 |
| 18 | IKBKE | 1.78265491 |
| 19 | JAK1 | 1.68730136 |
| 20 | FGR | 1.68157444 |
| 21 | DAPK2 | 1.66500216 |
| 22 | CSF1R | 1.63586906 |
| 23 | RIPK1 | 1.59755356 |
| 24 | CSK | 1.57909616 |
| 25 | ZAP70 | 1.54176423 |
| 26 | TAOK2 | 1.49082851 |
| 27 | EPHB1 | 1.48650883 |
| 28 | MAP3K11 | 1.43829140 |
| 29 | KSR2 | 1.43490520 |
| 30 | CAMKK1 | 1.43231691 |
| 31 | JAK3 | 1.43034868 |
| 32 | PIM2 | 1.39940778 |
| 33 | SMG1 | 1.39327326 |
| 34 | MAP3K12 | 1.37547989 |
| 35 | SIK3 | 1.35715337 |
| 36 | HCK | 1.32390820 |
| 37 | IKBKB | 1.28809316 |
| 38 | TAOK1 | 1.26624038 |
| 39 | GRK6 | 1.23478462 |
| 40 | BMX | 1.23157709 |
| 41 | SYK | 1.21783691 |
| 42 | MATK | 1.19308565 |
| 43 | JAK2 | 1.18523097 |
| 44 | SCYL2 | 1.14127472 |
| 45 | TXK | 1.10884776 |
| 46 | SIK1 | 1.07976005 |
| 47 | SIK2 | 1.07869750 |
| 48 | PTK6 | 1.07806687 |
| 49 | ARAF | 1.06029142 |
| 50 | MAP3K1 | 1.01119155 |
| 51 | ALK | 1.00791672 |
| 52 | STK10 | 1.00284981 |
| 53 | PRKD2 | 1.00274416 |
| 54 | MARK2 | 0.99825431 |
| 55 | NEK9 | 0.98867044 |
| 56 | LCK | 0.98205473 |
| 57 | PAK4 | 0.97100385 |
| 58 | MAP3K10 | 0.94953605 |
| 59 | MAP2K3 | 0.94422404 |
| 60 | CDC42BPA | 0.94178200 |
| 61 | LRRK2 | 0.91723789 |
| 62 | DMPK | 0.89111673 |
| 63 | IRAK2 | 0.88975149 |
| 64 | TESK1 | 0.88366640 |
| 65 | GRK7 | 0.88265885 |
| 66 | BTK | 0.86176775 |
| 67 | DAPK1 | 0.83770303 |
| 68 | TAOK3 | 0.82978243 |
| 69 | DAPK3 | 0.81191887 |
| 70 | CAMKK2 | 0.80593205 |
| 71 | PBK | 0.79974417 |
| 72 | PDK1 | 0.79959310 |
| 73 | LYN | 0.79002830 |
| 74 | PDPK1 | 0.76212285 |
| 75 | YES1 | 0.75697338 |
| 76 | NME2 | 0.71450771 |
| 77 | MAP3K5 | 0.71100870 |
| 78 | MAP3K3 | 0.69439382 |
| 79 | IRAK1 | 0.68779300 |
| 80 | PRKG2 | 0.68758710 |
| 81 | EGFR | 0.68648037 |
| 82 | CAMK1D | 0.68578568 |
| 83 | CLK1 | 0.66926954 |
| 84 | MOS | 0.66114970 |
| 85 | RPS6KA4 | 0.64751766 |
| 86 | TESK2 | 0.64243813 |
| 87 | MAPK12 | 0.64124467 |
| 88 | MAP3K6 | 0.62037655 |
| 89 | MST4 | 0.60502195 |
| 90 | ABL2 | 0.60327777 |
| 91 | ITK | 0.59711529 |
| 92 | FGFR4 | 0.59642506 |
| 93 | FGFR3 | 0.59592944 |
| 94 | HIPK2 | 0.57920627 |
| 95 | PTK2B | 0.56803247 |
| 96 | CAMK1G | 0.56275691 |
| 97 | PAK6 | 0.55793714 |
| 98 | CHUK | 0.53074496 |
| 99 | PRKCD | 0.52993163 |
| 100 | MAP3K7 | 0.51608662 |
| 101 | FYN | 0.51521306 |
| 102 | TEC | 0.51298168 |
| 103 | ICK | 0.50980622 |
| 104 | MAP3K8 | 0.50956909 |
| 105 | RET | 0.50519798 |
| 106 | RPS6KC1 | 0.50099591 |
| 107 | RPS6KL1 | 0.50099591 |
| 108 | PRKCH | 0.49688312 |
| 109 | MAPK7 | 0.49262817 |
| 110 | MAP2K6 | 0.47714483 |
| 111 | MAP3K2 | 0.47382329 |
| 112 | RAF1 | 0.47223366 |
| 113 | PIM1 | 0.46651991 |
| 114 | ABL1 | 0.46529770 |
| 115 | CDK19 | 0.41877495 |
| 116 | MAPKAPK2 | 0.41282784 |
| 117 | STK11 | 0.41212827 |
| 118 | CDK6 | 0.41090626 |
| 119 | MARK3 | 0.39692501 |
| 120 | STK38 | 0.38446964 |
| 121 | DYRK1B | 0.37525766 |
| 122 | TTN | 0.37283475 |
| 123 | PRKCQ | 0.37251264 |
| 124 | TNK2 | 0.36617177 |
| 125 | RPS6KA6 | 0.36598397 |
| 126 | CDK4 | 0.35695221 |
| 127 | MAPK4 | 0.35375591 |
| 128 | RPS6KA2 | 0.33752462 |
| 129 | SGK3 | 0.33656362 |
| 130 | BMPR2 | 0.33082249 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Leishmaniasis_Homo sapiens_hsa05140 | 2.87405675 |
| 2 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.85277215 |
| 3 | Osteoclast differentiation_Homo sapiens_hsa04380 | 2.50528517 |
| 4 | Lysosome_Homo sapiens_hsa04142 | 2.29757474 |
| 5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.24101232 |
| 6 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 2.21922816 |
| 7 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.14018344 |
| 8 | Tuberculosis_Homo sapiens_hsa05152 | 2.05909535 |
| 9 | Pertussis_Homo sapiens_hsa05133 | 2.04203412 |
| 10 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.95635445 |
| 11 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.84227762 |
| 12 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.81790544 |
| 13 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 1.77412536 |
| 14 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.70590188 |
| 15 | Salmonella infection_Homo sapiens_hsa05132 | 1.69702593 |
| 16 | Legionellosis_Homo sapiens_hsa05134 | 1.67541217 |
| 17 | Other glycan degradation_Homo sapiens_hsa00511 | 1.66798505 |
| 18 | Graft-versus-host disease_Homo sapiens_hsa05332 | 1.62364089 |
| 19 | Antigen processing and presentation_Homo sapiens_hsa04612 | 1.57199028 |
| 20 | Shigellosis_Homo sapiens_hsa05131 | 1.52820583 |
| 21 | Phagosome_Homo sapiens_hsa04145 | 1.52151851 |
| 22 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.49243668 |
| 23 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.45107738 |
| 24 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.43759677 |
| 25 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.42949593 |
| 26 | Malaria_Homo sapiens_hsa05144 | 1.42746874 |
| 27 | Measles_Homo sapiens_hsa05162 | 1.40278915 |
| 28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.40127481 |
| 29 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.39106460 |
| 30 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.38919636 |
| 31 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.30706405 |
| 32 | Influenza A_Homo sapiens_hsa05164 | 1.30375281 |
| 33 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.29705102 |
| 34 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.27426534 |
| 35 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.17483022 |
| 36 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.16519826 |
| 37 | Apoptosis_Homo sapiens_hsa04210 | 1.12312815 |
| 38 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.12082717 |
| 39 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.08791685 |
| 40 | Allograft rejection_Homo sapiens_hsa05330 | 1.07021378 |
| 41 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 1.03050852 |
| 42 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.01934116 |
| 43 | VEGF signaling pathway_Homo sapiens_hsa04370 | 1.01819465 |
| 44 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.99490417 |
| 45 | Hepatitis B_Homo sapiens_hsa05161 | 0.99342467 |
| 46 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.99340588 |
| 47 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.97520387 |
| 48 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.96700637 |
| 49 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.96241948 |
| 50 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.94649376 |
| 51 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.93450904 |
| 52 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 0.91670149 |
| 53 | Endocytosis_Homo sapiens_hsa04144 | 0.91057655 |
| 54 | Platelet activation_Homo sapiens_hsa04611 | 0.90757124 |
| 55 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.89173613 |
| 56 | Amoebiasis_Homo sapiens_hsa05146 | 0.87980798 |
| 57 | Asthma_Homo sapiens_hsa05310 | 0.86900235 |
| 58 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.84120041 |
| 59 | Hepatitis C_Homo sapiens_hsa05160 | 0.83702718 |
| 60 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.83665336 |
| 61 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 0.83159581 |
| 62 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.82663323 |
| 63 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.81565732 |
| 64 | Viral myocarditis_Homo sapiens_hsa05416 | 0.78573409 |
| 65 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.78478274 |
| 66 | Prion diseases_Homo sapiens_hsa05020 | 0.78257843 |
| 67 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.77071387 |
| 68 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.76271542 |
| 69 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.73474818 |
| 70 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.73329069 |
| 71 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.71237816 |
| 72 | Glioma_Homo sapiens_hsa05214 | 0.70682939 |
| 73 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.70342185 |
| 74 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69206158 |
| 75 | Mineral absorption_Homo sapiens_hsa04978 | 0.68875537 |
| 76 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.68357541 |
| 77 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.67341832 |
| 78 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 0.66974058 |
| 79 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.66332925 |
| 80 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.65604678 |
| 81 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.65515565 |
| 82 | Primary immunodeficiency_Homo sapiens_hsa05340 | 0.63615181 |
| 83 | Bladder cancer_Homo sapiens_hsa05219 | 0.62137035 |
| 84 | HTLV-I infection_Homo sapiens_hsa05166 | 0.58796567 |
| 85 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57573230 |
| 86 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.57522972 |
| 87 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.56865608 |
| 88 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.54201200 |
| 89 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.53055672 |
| 90 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.52632873 |
| 91 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.52292456 |
| 92 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.52284524 |
| 93 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.51911645 |
| 94 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.50985925 |
| 95 | Endometrial cancer_Homo sapiens_hsa05213 | 0.50680897 |
| 96 | Olfactory transduction_Homo sapiens_hsa04740 | 0.49979683 |
| 97 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.49075200 |
| 98 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.49070466 |
| 99 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.47521750 |
| 100 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.47047668 |
| 101 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.47008667 |
| 102 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.46782504 |
| 103 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.46649257 |
| 104 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.45648797 |
| 105 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.45222140 |
| 106 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.45025127 |
| 107 | Galactose metabolism_Homo sapiens_hsa00052 | 0.43997037 |
| 108 | Insulin resistance_Homo sapiens_hsa04931 | 0.43485825 |
| 109 | Salivary secretion_Homo sapiens_hsa04970 | 0.43072867 |
| 110 | Renin secretion_Homo sapiens_hsa04924 | 0.41720773 |
| 111 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.41232866 |
| 112 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.40692381 |
| 113 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.40439812 |
| 114 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.40401555 |
| 115 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.40075700 |
| 116 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.39609333 |
| 117 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.39421400 |
| 118 | Colorectal cancer_Homo sapiens_hsa05210 | 0.38751790 |
| 119 | Long-term potentiation_Homo sapiens_hsa04720 | 0.38353686 |
| 120 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38252012 |
| 121 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.36597951 |

